Applications of 1-(3-Methylphenyl)Piperazine Dihydrochloride Hydrate in Industrial Manufacturing

As the original producer of 1-(3-Methylphenyl)Piperazine Dihydrochloride Hydrate, we provide this specialty chemical for use in several controlled and regulated downstream sectors. This section outlines practical and industrial-scale applications across major chemical and pharmaceutical fields, focusing on manufacturing practices, compliance, and precise process requirements.

1. Active Pharmaceutical Ingredient Intermediate Synthesis

Manufacturers in the pharmaceutical sector use this compound as a key building block for certain psychoactive drug intermediates and antipsychotic active pharmaceutical ingredients. Production batches require stringent control over impurity profiles, with our material often introduced at a late stage of multi-step synthesis. Accurate formulation and traceability are essential for regulatory filing and patent clearance. Quality control must meet synthesis batch reproducibility for global registration.

Industry compliance standards

• ICH Q7A Good Manufacturing Practice (GMP) for APIs
• 21 CFR Part 210/211 (US FDA)
• EU EudraLex Volume 4
• Chinese Pharmacopoeia & DMF submission standards

Typical usage ratio

• 0.2–1.1 molar equivalents per target molecule, optimized as per patent and route requirements.

Downstream process integration

• Charged directly into reactor vessels during one-pot amination or piperazine ring formation steps.
• Enters the route prior to final crystallization, enabling isolation of high-purity intermediates.
• Can be introduced as a hydrochloride hydrate to control stoichiometry and salt formation.

Final product types

• Quetiapine fumarate intermediates
• Aripiprazole key intermediates
• Trazodone-related APIs
• CNS-active pharmaceutical candidates

2. Custom Synthesis for Chemical Contract Manufacturers (CMO/CDMO)

Custom manufacturing houses apply this compound in contract-based production of protected heterocycles and advanced intermediates for research clients and scale-up projects. Each project demands tailored documentation, MSDS disclosure, and reproducible synthesis routes. Detailed process validation and analytical verification play a critical role due to batch-to-batch variation controls and IP-related restrictions. Documentation must meet the end client’s tech transfer requirements.

Industry compliance standards

• ISO 9001:2015 Quality Management System
• Custom project-specific NDA and intellectual property compliance
• REACH (EU) registration where required
• Client-specific quality agreements and audit protocols

Typical usage ratio

• Varies from 1–5% by mass in small-scale organic transformations; adjusted per customer route.

Downstream process integration

• Introduced to multi-liter glass reactors for gram-to-kilogram scale synthesis runs.
• Charged as a salt or as a solution in controlled environment rooms.
• Handles in weighing booths under cGMP or cGxP supervision for process development.

Final product types

• Protected piperazine derivatives for clinical trial supply
• Custom intermediates for pharma and biotech pipelines
• Fine chemical sample libraries
• Small molecule probes for advanced R&D

3. Chemical Reference Standards for Quality Control Laboratories

Analytical laboratories, reference material providers, and pharma QC departments purchase this material for the calibration of analytical instruments, method development, and the creation of secondary standards. High purity, batch certification, and traceability are non-negotiable, as accuracy in standard preparation directly impacts validation of commercial APIs and regulated substances. Conformance to reference material procedures is essential for audit traceability.

Industry compliance standards

• ISO 17034 (General Requirements for the Competence of Reference Material Producers)
• USP–NF secondary reference standard requirements
• WHO GMP for laboratory chemicals
• Pharmacopoeial monograph alignment (as applicable)

Typical usage ratio

• Typically 0.01–0.2% by mass for standard and spiking solutions in analytical runs.

Downstream process integration

• Dissolved in HPLC-grade solvents for calibration mixtures.
• Prepared in certified balances and cleanroom grade weighing rooms.
• Used as reference in assay, purity, and stability-indicating methods.

Final product types

• Certified chemical reference standards (CRMs)
• Analytical primary and secondary standards
• Traceable assay controls for pharmaceutical testing
• Proficiency test samples

4. Fine Chemicals for Small-Molecule R&D and Discovery Chemistry

Research and discovery units utilize the compound as a source of piperazine functionality within medicinal chemistry, SAR studies, and patent innovation. Material selection prioritizes impurity profile and synthetic versatility with a focus on robust documentation (COA, NMR, HPLC). Research groups may use this compound in mg-to-g quantities, often cycling between batch and parallel synthesis setups.

Industry compliance standards

• GLP (Good Laboratory Practice) for synthesis and analytical work
• Record-keeping as per OECD Principles
• Material Safety Data Sheet (MSDS) access and compliance

Typical usage ratio

• Typically 0.1–2 equivalents based on synthetic targets; ratio adjusted in screening versus scale.

Downstream process integration

• Weighed directly into round-bottom flasks for small-scale batch reactions.
• Used as a core scaffold in organic transformations or functional group manipulations.
• Provides the piperazine moiety for lead diversification and analog synthesis.

Final product types

• Novel drug candidates for early-stage evaluation
• Compound libraries for screening
• Molecular patent submissions
• Research intermediates for collaboration projects